https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 A randomized placebo-controlled trial on the effects of Menthacarin, a proprietary peppermint- and caraway-oil-preparation, on symptoms and quality of life in patients with functional dyspepsia https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:34216 Wed 20 Feb 2019 10:05:28 AEDT ]]> Transdiagnostic internet-delivered cognitive-behaviour therapy (CBT) for adults with functional gastrointestinal disorders (FGID): A feasibility open trial https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:42026 Wed 17 Aug 2022 11:10:20 AEST ]]> The validity of a new structured assessment of gastrointestinal symptoms scale (SAGIS) for evaluating symptoms in the clinical setting https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:31849 n = 596) and validation datasets (n = 551). Discriminant validity along with test–retest reliability was assessed. The time taken to perform a clinical assessment with and without the SAGIS was recorded along with doctor satisfaction with this tool. Results: Exploratory factor analysis conducted on the derivation sample suggested five symptom constructs labeled as abdominal pain/discomfort (seven items), gastroesophageal reflux disease/regurgitation symptoms (four items), nausea/vomiting (three items), diarrhea/incontinence (five items), and difficult defecation and constipation (2 items). Confirmatory factor analysis conducted on the validation sample supported the initially developed five-factor measurement model (χ2193=892.2, p < 0.0001, χ2/df = 4.6, CFI = 0.90, TLI = 0.88, RMSEA = 0.08). All symptom groups demonstrated differentiation between disease groups. The SAGIS was shown to be reliable over time and resulted in a 38% reduction of the time required for clinical assessment. Conclusions: The SAGIS instrument has excellent psychometric properties and supports the clinical assessment of and symptom-based categorization of patients with a wide spectrum of gastrointestinal symptoms.]]> Sat 24 Mar 2018 08:43:15 AEDT ]]> A preliminary analysis of the effect Iberogast, Nexium, dual Iberogast + Nexium or dual placebo on symptoms in patients with functional dyspepsia https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:13239 Sat 24 Mar 2018 08:17:36 AEDT ]]> Characterisation of the gastrointestinal mucosa-associated microbiota: a novel technique to prevent cross-contamination during endoscopic procedures https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:24505 Sat 24 Mar 2018 07:13:10 AEDT ]]> Investigating the intestinal mucosa-associated microbiota – relevance and potential pitfalls: authors’ reply (letter) https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:24506 Sat 24 Mar 2018 07:13:10 AEDT ]]>